Immune EVaders: The Next Generation Therapeutic Agent With Amy Kauffman

Video

Published: August 25, 2022

Lucy Lawrence

From COVID to chronic infections and cancer, stem cell-derived extracellular vesicles (EVs) have the potential to change the landscape of regenerative medicine and inflammatory conditions treatments. Though still in early-stage research, EVs already appear to hold great promise.

This Teach Me in 10 will cover what EVs are, the therapeutic promise they hold as well as guidance on how to culture and scale.

Dr. Kauffman recommends taking a look at the following resources:

Meet the Author

Lucy Lawrence

Senior Digital Content Producer

Lucy Lawrence is the Senior Digital Content Producer at Technology Networks. Her unwavering belief in the transformative power of science drives her to create exceptional content that educates, inspires, and entertains.